"Tuberculosis, Pulmonary" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
MYCOBACTERIUM infections of the lung.
Descriptor ID |
D014397
|
MeSH Number(s) |
C01.252.410.040.552.846.899 C08.381.922 C08.730.939
|
Concept/Terms |
Tuberculosis, Pulmonary- Tuberculosis, Pulmonary
- Tuberculoses, Pulmonary
- Pulmonary Tuberculoses
- Pulmonary Tuberculosis
- Pulmonary Consumption
- Consumption, Pulmonary
- Consumptions, Pulmonary
- Pulmonary Consumptions
- Pulmonary Phthisis
- Phthises, Pulmonary
- Phthisis, Pulmonary
- Pulmonary Phthises
|
Below are MeSH descriptors whose meaning is more general than "Tuberculosis, Pulmonary".
Below are MeSH descriptors whose meaning is more specific than "Tuberculosis, Pulmonary".
This graph shows the total number of publications written about "Tuberculosis, Pulmonary" by people in this website by year, and whether "Tuberculosis, Pulmonary" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 4 | 0 | 4 |
1996 | 3 | 0 | 3 |
1997 | 0 | 1 | 1 |
1999 | 2 | 0 | 2 |
2000 | 1 | 0 | 1 |
2001 | 2 | 0 | 2 |
2002 | 2 | 1 | 3 |
2003 | 4 | 3 | 7 |
2004 | 6 | 1 | 7 |
2005 | 5 | 1 | 6 |
2006 | 5 | 3 | 8 |
2007 | 4 | 0 | 4 |
2008 | 3 | 0 | 3 |
2009 | 4 | 0 | 4 |
2010 | 1 | 0 | 1 |
2011 | 5 | 0 | 5 |
2012 | 6 | 0 | 6 |
2013 | 7 | 0 | 7 |
2014 | 9 | 0 | 9 |
2015 | 10 | 1 | 11 |
2016 | 12 | 2 | 14 |
2017 | 8 | 4 | 12 |
2018 | 5 | 1 | 6 |
2019 | 3 | 3 | 6 |
2020 | 5 | 0 | 5 |
2021 | 7 | 1 | 8 |
2022 | 4 | 0 | 4 |
2023 | 5 | 0 | 5 |
2024 | 4 | 2 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Tuberculosis, Pulmonary" by people in Profiles.
-
The molecular bacterial load assay predicts treatment responses in patients with pre-XDR/XDR-tuberculosis more accurately than GeneXpert Ultra MTB/Rif. J Infect. 2025 Feb; 90(2):106399.
-
Whispers in the Wind: Face Mask Sampling for Mycobacterium tuberculosis Detection in Children With Pulmonary Tuberculosis. J Infect Dis. 2024 Dec 16; 230(6):1510-1517.
-
Parallel use of low-complexity automated nucleic acid amplification tests on respiratory samples and stool with or without lateral flow lipoarabinomannan assays to detect pulmonary tuberculosis disease in children. Cochrane Database Syst Rev. 2024 05 13; 5:CD016071.
-
Parallel use of low-complexity automated nucleic acid amplification tests and lateral flow urine lipoarabinomannan assays to detect tuberculosis disease in adults and adolescents living with HIV. Cochrane Database Syst Rev. 2024 05 13; 5:CD016070.
-
A stool based qPCR for the diagnosis of TB in children and people living with HIV in Uganda, Eswatini and Mozambique (Stool4TB): a protocol for a multicenter diagnostic evaluation. BMC Infect Dis. 2024 Feb 21; 24(1):233.
-
A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial. Nat Med. 2024 Mar; 30(3):896-904.
-
Effectiveness of a community-based approach for the investigation and management of children with household tuberculosis contact in Cameroon and Uganda: a cluster-randomised trial. Lancet Glob Health. 2023 Dec; 11(12):e1911-e1921.
-
Transrenal Mycobacterium tuberculosis DNA in pulmonary tuberculosis patients during the first 14 days of treatment. Microbiol Spectr. 2023 Dec 12; 11(6):e0234823.
-
Global treatment outcomes of extensively drug-resistant tuberculosis in adults: A systematic review and meta-analysis. J Infect. 2023 09; 87(3):177-189.
-
Development of treatment-decision algorithms for children evaluated for pulmonary tuberculosis: an individual participant data meta-analysis. Lancet Child Adolesc Health. 2023 05; 7(5):336-346.